Zhejiang Xianju Pharmaceutical Co Ltd (002332) — Free Cash Flow Generation Index
Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a Free Cash Flow Generation Index of 0.77x as of September 2025. Free cash flow of CN¥100.04 Million represents 1% of operating cash flow (CN¥130.05 Million). Read Zhejiang Xianju Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang Xianju Pharmaceutical Co Ltd Free Cash Flow Generation Index (2006–2025)
Historical FCF Generation Index trend for Zhejiang Xianju Pharmaceutical Co Ltd across 20 annual periods. Explore Zhejiang Xianju Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2025)
Year-by-year Free Cash Flow Generation Index for Zhejiang Xianju Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see how much is Zhejiang Xianju Pharmaceutical Co Ltd worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.16x | CN¥38.40 Million | CN¥247.48 Million | CN¥209.07 Million | ▼ -67.6% |
| 2024 | 0.48x | CN¥191.07 Million | CN¥398.66 Million | CN¥207.59 Million | ▼ -20.9% |
| 2023 | 0.61x | CN¥360.85 Million | CN¥595.48 Million | CN¥234.63 Million | ▲ +13.0% |
| 2022 | 0.54x | CN¥326.74 Million | CN¥609.28 Million | CN¥282.54 Million | ▼ -11.4% |
| 2021 | 0.61x | CN¥409.31 Million | CN¥676.15 Million | CN¥266.84 Million | ▼ -28.8% |
| 2020 | 0.85x | CN¥671.06 Million | CN¥789.23 Million | CN¥118.17 Million | ▲ +71.7% |
| 2019 | 0.50x | CN¥257.46 Million | CN¥519.81 Million | CN¥262.34 Million | ▲ +298.7% |
| 2018 | 0.12x | CN¥24.01 Million | CN¥193.27 Million | CN¥169.26 Million | ▼ -52.9% |
| 2017 | 0.26x | CN¥44.18 Million | CN¥167.47 Million | CN¥123.28 Million | ▼ -30.1% |
| 2016 | 0.38x | CN¥58.80 Million | CN¥155.91 Million | CN¥97.10 Million | ▼ -11.0% |
| 2015 | 0.42x | CN¥84.56 Million | CN¥199.61 Million | CN¥115.05 Million | ▲ +79.7% |
| 2014 | 0.24x | CN¥33.38 Million | CN¥141.64 Million | CN¥108.26 Million | ▲ +111.9% |
| 2013 | -1.98x | CN¥-125.80 Million | CN¥63.46 Million | CN¥189.26 Million | ▲ +75.0% |
| 2012 | -7.91x | CN¥-264.58 Million | CN¥33.43 Million | CN¥298.01 Million | ▼ -823.6% |
| 2011 | -0.86x | CN¥-126.51 Million | CN¥147.63 Million | CN¥274.14 Million | ▼ -243.5% |
| 2010 | 0.60x | CN¥92.71 Million | CN¥155.29 Million | CN¥62.58 Million | ▲ +1.2% |
| 2009 | 0.59x | CN¥61.74 Million | CN¥104.68 Million | CN¥42.94 Million | ▲ +191.5% |
| 2008 | -0.64x | CN¥-23.22 Million | CN¥36.03 Million | CN¥59.25 Million | ▼ -314.6% |
| 2007 | 0.30x | CN¥28.99 Million | CN¥96.53 Million | CN¥67.55 Million | ▼ -3.7% |
| 2006 | 0.31x | CN¥16.54 Million | CN¥53.05 Million | CN¥36.51 Million | — |